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(B), each with distinct connections (Pitkänen et al., 1997), and the 
LA, but not the B, is necessary for fear conditioning (Amorapanth 
et al., 2000; Nader et al., 2001). Moreover, the results of these 
ultrastructural NE studies differed: one study showed that within 
the basal complex, NE terminals rarely formed synapses (Asan, 
1998) while another showed a greater proportion of NE terminals 
forming synapses, including with other terminals (Li et al., 2001). 
Electrophysiological studies have shown that βARs play a role in 
synaptic transmission (Gean et al., 1992; Huang et al., 1993, 1996; 
Ferry et al., 1997; Buffalari and Grace, 2007) and LTP (Johnson 
et al., 2006) in the amygdala. While anatomical studies have char-
acterized the cellular and subcellular distribution of βARs in other 
brain regions (Aoki et al., 1989; Aoki, 1992, 1997; Aoki and Pickel, 
1992; Milner et al., 2000), little is known about the cellular and 
subcellular distribution of βARs within the amygdala. Using com-
mercial antibodies directed against the β1 and β2 receptor subtypes, 
one confocal microscopic study found that the β1 and β2 receptor 
subtypes are widely distributed in basal amygdala neurons but not 
in astrocytes (Qu et al., 2008). This group also found that while 
both receptor subtypes were seen in the membranes and cytoplasm 
of cell bodies, the β2 receptor subtype, but not the β1, was localized 
to the nucleus. To understand better the cellular mechanisms of 
NE’s contributions to fear learning, we examined the anatomical 
IntroductIon
Norepinephrine (NE) has long been implicated in fear and anxi-
ety (Gray, 1978; Redmond, 1979; Aston-Jones and Bloom, 1981; 
Aston-Jones et al., 1999, 2000; Sullivan et al., 1999), and is known 
to play a role in learning and memory (Ferry et al., 1997; Bailey 
et al., 2000; McGaugh, 2002). However, the contribution of NE to 
Pavlovian fear conditioning, a leading model for understanding 
the neural basis of fear and anxiety and learning and memory, 
is poorly understood. Recent studies suggest that NE contributes 
to the acquisition but not the consolidation of fear conditioning 
(Lee et al., 2001; Debiec and LeDoux, 2004; Grillon et al., 2004; 
Murchison et al., 2004; Bush et al., 2010). The lateral nucleus of the 
amygdala (LA) is a critical brain region for fear learning (LeDoux, 
2000, 2007; Rodrigues et al., 2004; Maren, 2005; Lang and Davis, 
2006) and blocking beta-adrenergic receptors (βARs) within the 
LA disrupts the acquisition of fear conditioning (Bush et al., 2010). 
Previous studies have shown that the amygdala is extensively inner-
vated by noradrenergic fibers, primarily originating from the locus 
coerulus (Moore and Card, 1984; Fallon and Ciofi, 1992; Asan, 1993, 
1998). Several studies have examined the ultrastructural relations 
of NE terminals in the basolateral complex or basolateral nucleus 
(BLA) (Asan, 1993, 1998; Li et al., 2001, 2002). However, the BLA 
contains two major subdivisions, the LA and the basal nucleus 
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organization of NE terminals and βARs in the LA. In this study, 
we employed immunoelectron microscopy to determine whether 
terminals immunoreactive for dopamine beta-hydroxylase (DβH), 
the synthetic enzyme for NE, form synaptic junctions in the LA 
and if so, examine these synapses and identify the post-synaptic 
targets on NE terminals. To determine the cellular and subcellular 
distributions of βARs in the LA, we used previously character-
ized antibodies directed against two different isoforms of βARs: 
βAR 248, an antibody that predominately recognizes neurons, and 
βAR404, which primarily detects astrocytes.
MaterIals and Methods
Male Sprague–Dawley (Hilltop Lab Animals, Inc; Scottdale, PA, 
USA) rats weighing 300–400 g (n = 8) were used for studies. All 
procedures  used  were  approved  by  the  Animal  Use  and  Care 
Committee of New York University, and conform to the guide-
lines of the National Institutes of Health on Care and Use of 
Experimental Animals in Research.
tIssue fIxatIon
Naïve  animals  were  anaesthetized  with  chloral  hydrate  (25%; 
1–1.5 g/kg BW) and transcardially perfused with 25–30 ml of 
heparinized 0.9% saline followed by either: 50 ml of 3.0% acrolein 
mixed into 4% paraformaldehyde (PFA), followed by 450 ml of 
4% PFA dissolved in 0.1 M phosphate buffer (PB, pH 7.4; n = 4), 
or 500 ml 0.1% glutaraldehyde/4% PFA (n = 4). The brains were 
removed from the skull, blocked, and post-fixed in 4% PFA for 
30 min. Blocks containing the amygdala were cut on a Vibratome 
and 40-μm coronal sections were collected. Tissue sections were 
treated with 1% sodium borohydride in PB for 30 min and rinsed 
with phosphate-buffered saline (0.01 M PBS, pH. 7.4).
IMMunocytocheMIcal labelIng
Following rinses in PBS, tissue sections were preincubated in PBS 
containing 1% (w:v) bovine serum albumin (BSA) for 30 min. 
The sections were incubated overnight at room temperature with 
either a mouse monoclonal antibody directed against DβH (1:500; 
Millipore, Temecula, CA, USA) or rabbit polyclonal antiserum 
directed against the one of the β-adrenergic receptors. The fol-
lowing day, the tissue was rinsed in PBS, incubated for 30 min in a 
solution containing a 1:200 dilution of either goat anti-mouse for 
DβH or goat anti-rabbit biotinylated IgG for βAR (1:200; Vector 
Labs, Burlingame, CA, USA), rinsed, and incubated for 30 min 
in ABC (Vector Labs) solution. The reaction product was then 
visualized by incubation in 0.022 % 3-3′-diaminobenzidine (DAB; 
Sigma, St. Louis, MO, USA) and 0.003% hydrogen peroxide. All 
primary and secondary antisera incubations included 1% BSA and 
diluents containing PBS. Triton-X was added to the DβH primary 
antibody solution (0.2% for light microscopy, 0.05% for electron 
microscopy). All incubations were performed at room temperature 
with continuous agitation. For dual-label fluorescent experiments, 
tissue was incubated overnight in βAR 248 as described above, 
rinsed, and incubated with goat anti-rabbit IgG conjugated to Alexa 
594 (1:200; Invitrogen, Carlsbad, CA, USA) for 1 h. The tissue was 
then rinsed, preincubated in 1% BSA and incubated overnight in 
either antibodies made in mouse either to GABA (1:2000; ICN 
Biochemicals, Costa Mesa, CA, USA) or CAMKII (1:200; Upstate, 
Lake Placid, NY, USA). The following day, the tissue was rinsed, 
and incubated in goat anti-mouse conjugated to Alexa 488 (1:200). 
Tissue sections for light and confocal microscopy were mounted 
on slides coated with gelatin. Tissue sections designated for LM 
analysis were dehydrated in a graded series of alcohol, defatted 
in xylene and coverslippped with Permount (Fisher Scientific). 
Fluorescent tissue was mounted and coverslipped with Prolong 
Gold (Invitrogen). The final preparations were examined on either 
a Nikon FXA and photographed with a Coolsnap digital camera 
(Roper Scientific, Trenton, NJ, USA) or a Zeiss LSM 310 and Leica 
TCS SP2 confocal microscope.
electron MIcroscopIc processIng
Tissue  sections  designated  for  EM  were  processed  as  previously 
described (Farb and LeDoux, 1997). In brief, tissue sections   containing 
the amygdala were incubated in 1% osmium tetraoxide/PB, dehy-
drated in a graded series of alcohols, stained en bloc in uranyl acetate, 
further dehydrated in acetone and subsequently flat-embedded in 
EMbed. Portions of the tissue containing the amygdala were cut and 
glued (Super Glue; Rancho Cucamonga, CA, USA) onto Beem cap-
sules and placed at 60°C for 10 min. Photographs of the amygdala were 
taken and ultrathin sections (85 nm) were cut from the dorsolateral 
division of the LA (Figure 1A). Ultrathin sections were collected on 
8–12 nickel grids and the tissue was examined on a JEOL 1200EX 
electron   microscope. Photographs were taken using a Hammamatsu 
digital camera (AMT; Danvers, MA, USA). Electron micrographs were 
collected from the dorsolateral amygdala of four animals with the best 
morphological preservation. For each brain, ultrathin sections from at 
least two vibratome sections containing the AL were examined. Labeled 
terminals were identified by the presence of peroxidase reaction prod-
uct within processes and were distinguished from preterminal axons 
by the presence of vesicles. Immunoreactive terminals without distinct 
membrane boundaries or whose peroxidase reaction product was too 
dense to distinguish between it and the post-synaptic density were not 
included in the analysis. Immunoreactive terminals were characterized 
as either forming or not forming synaptic contacts by the presence 
of a post-synaptic membrane specialization, intercleft filaments, and 
widened (10–20 nm) parallel spacing of plasma membranes (Peters 
et al., 1991). Labeled terminals with thickened post-synaptic densi-
ties and widened synaptic clefts were classified as asymmetric while 
terminals with thin post-synaptic densities and narrower synaptic 
clefts were identified as symmetric. Appositions were characterized 
by close membrane associations not separated by astrocytic processes, 
the lack of conventional synaptic clefts, intercleft material or dense 
  specializations. Dendritic shafts were arbitrarily characterized as large 
(i.e. proximal) if their diameter was greater than 0.5 μm, or small 
(i.e., distal) if their diameter was less than 0.5 μm. Dendritic spines   
were smaller than dendrites and lacked mitochondria.
antIbody specIfIcIty
In  this  study,  we  used  mouse  monoclonal  antibodies  directed 
against DβH, CAMKII, and GABA that have been characterized 
in previously published reports (Li et al., 2002; McDonald et al., 
2002; Balcita-Pedicino and Rinaman, 2007; Schiltz and Sawchenko, 
2007; Howorth et al., 2009). The pattern of DβH-immunoreactivity 
we describe is consistent with previously published reports in the 
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examined the tissue by confocal microscopy. We also dually labeled 
tissue for βAR 248 and GABA to establish whether GABAergic cells 
contain βARs. By confocal microscopy, βARs were localized to both 
LA excitatory and inhibitory cells (Figures 2A,B).
electron MIcroscopy
Most DβH terminals do not form synapses within single sections
Most of our EM analysis was performed on tissue fixed with acro-
lein since both the ultrastructure and membrane preservation were 
superior to tissue fixed with low levels of glutaraldehyde. Four hun-
Roder and Ciriello, 1993; Asan, 1993, 1998; Li et al., 2001, 2002). Earlier 
studies have shown that within the LA, DβH is a specific marker for 
NE and does not label the other catecholaminergic   biosynthetic 
enzymes, phenyl-methyl transferase (PNMT), the marker for adren-
ergic axons, or tyrosine-hydroxylase (TH), the marker for dopamin-
ergic axons (Fallon et al., 1978; Fallon and Ciofi, 1992; Asan, 1993; 
Roder and Ciriello, 1993). Specifically, these studies have shown that 
PNMT immunoreactivity in the LA is scarce or nearly absent while 
TH-ir differs markedly and is non-overlapping. We also used rabbit 
antisera directed against β2AR that was generated by using   synthetic 
peptides corresponding to amino acids 248–256 (βAR 248) and 404–
418 (βAR 404) of hamster lung β2ARs (Dixon et al., 1986). The βAR 
404 antiserum recognizes both the β1- and β2-subtypes (Strader et al., 
1987a,b). The antiserum to βAR 248 (1:1K) was directed against the 
third cytoplasmic loop while the antiserum for βAR 404 (1:1K) was 
directed against the C-terminus of the receptor. The specificity of 
βAR 404 antisera has been previously characterized using Western 
blot (Strader et al., 1987b) and immunoprecipitation of radiolabeled 
βAR (Strader et al., 1987a). Preadsorption controls to the synthetic 
peptides using the exact correspondence to the antigens that were 
used to generate the βAR 248 and 404 antisera were also performed 
(Aoki, 1997). Antisera against βAR 248 and βAR 404 were generously 
provided by Dr. C.D Strader of Merck Sharp and Dohme Research 
Laboratories. Immunoreactivity was absent from tissue in which the 
primary antisera was omitted from the incubation solutions or the 
secondary antibody was mismatched to the primary antibody, e.g., 
anti-mouse IgG instead of the anti-rabbit IgG, and the tissue was 
reacted as described above.
results
lIght MIcroscopy
The LA contains a dense plexus of dopamine beta-hydroxylase fibers
The pattern of DβH-immunoreactivity (-ir) in the amygdala has 
been described previously (Moore and Card, 1984; Fallon and Ciofi, 
1992; Asan, 1993, 1998; Li et al., 2001, 2002). In brief, in both glutar-
aldehyde and acrolein-fixed tissue, DβH fibers appeared as a dense 
plexus and were distributed throughout the LA (Figure 1A). DβH 
fibers were fine and varicose and coursed through the amygdala in 
both dorsal–ventral and medial–lateral directions (Figure 1B).
Beta-adrenergic receptor immunoreactivity occurs throughout the LA
Immunoreactivity for both β2AR antisera was distributed through-
out  the  LA.  By  light  microscopy,  numerous  cells  were  labeled. 
(Figures 1C,D). βAR 248 densely labeled neuronal perikarya and 
the proximal portions of their dendrites. In some LA cells, the 
reaction product rimmed the cytoplasm and the nucleus was well 
delineated whereas in other cells, the reaction product obscured the 
nuclei (Figure 1E). βAR 404-ir was observed in small cell bodies 
that appeared astrocytic: many labeled processes radiated from small 
perikarya (Figure 1F). Some labeled processes followed the contours 
of blood vessels.
confocal MIcroscopy reveals βars are localIzed to both 
excItatory and InhIbItory cells
To determine whether βAR248 was localized to specific cells types, 
we dually labeled tissue for βAR248 and CAMKII, a marker for exci-
tatory, pyramidal-like cells in the LA (McDonald et al., 2002) and 
Figure 1 | Light micrographs showing dopamine beta-hydroxylase 
(DβH) and beta-adrenergic receptors (βArs) in the amygdala. (A) Dark-
field micrograph shows DβH in the amygdala. Trapezoid corresponds to area 
examined by electron microscopy. (B) Higher-magnification dark-field 
micrograph illustrates thin, varicose DβH axons. Arrowheads point to 
varicosities. (C,D) Low-magnification bright-field micrographs show βAR 248 
(C), and βAR 404 (D) are distributed homogenously throughout the amygdala. 
(e) Higher magnification shows that βAR 248 intensely labels somata and 
some proximal dendrites (arrowheads). The nuclei of some labeled cells are 
seen in some cells (arrows) but are difficult to distinguish in others. 
(F) Higher-power Nomarski optics show labeled astrocytic cell bodies 
(arrowheads) and their radiating processes (arrows). Also shown is an 
astrocytic process (asterisks) surrounding a blood vessel (BV). Scale 
bar = 100 μm in A–D, 50 μm in B, e, and F. BLA, basolateral amygdala; Ce, 
central amygdala; LA, lateral amygdala.Frontiers in Behavioral Neuroscience  www.frontiersin.org  October 2010  | Volume 4  | Article 162  |  4
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βar IMMunoreactIvIty
βAR 248 is frequently localized to post-synaptic densities. By elec-
tron microscopy, βAR 248-ir was localized to neuronal perikarya, 
large and small dendritic shafts, dendritic spines, some axon ter-
minals, and astrocytic processes (Figures 6A–C). Within dendritic 
shafts, reaction product rimmed the microtubules and the mito-
chondrial membranes, and in both shafts and spines was frequently 
concentrated along the plasma membranes and at post-synaptic 
densities (Figures 6A–C). βAR 248-ir axon terminals forming 
asymmetric synapses were occasionally observed (Figure 6B). βAR 
248-ir was seen in perikarya with the morphological features of 
both inhibitory, e.g., invaginated nuclei and abundant cytoplasm, 
and excitatory cells, e.g., large nuclei and a thin rim of cytoplasm 
(Ribak and Seress, 1983; Farb et al., 1995). The subcellular distribu-
tion of βAR 248 immunoreactivity was consistent with previously 
published studies (Aoki, 1992, 1997).
βAR  404  is  predominantly  localized  to  glial  processes. 
Ultrastructural examination revealed that βAR 404 was predomi-
nantly localized to glial perikarya and processes but some neuronal 
processes were also immunoreactive (Figures 6D–F). Glial peri-
karya were distinguished from neuronal perikarya by the pres-
ence of filamentous organelles or glycogen granules whereas glial 
processes were recognized by their irregular contours and scarcity 
of organelles. When βAR 404 immunoreactivity occurred in large 
glial processes, the immunoperoxidase product rimmed the glial 
vesicles and mitochondria but was frequently concentrated along 
the plasma membranes (Figure 6E). Labeled glial processes fre-
quently ensheathed or directly apposed unlabeled terminals form-
ing asymmetric terminals (Figures 6D–F). Often, small labeled 
glial processes were interposed between unlabeled axon terminals 
(Figure 6D). Some axon terminals and dendritic shafts and spines 
were also immunoreactive for βAR 404 (Figures 6D,F). Large glial 
processes intensely immunoreactive for βAR 404 were sometimes 
apposed to the basal lamina and endothelial cells that bounded 
blood vessels (Figure 4B).
dred and ten DβH-labeled terminals were analyzed from tissue 
taken from the four animals with the best morphology. Analysis 
was performed on three animals perfused with acrolein and one 
animal perfused with glutaraldehyde. Ultrathin sections were col-
lected from 3–4 vibratome sections from each animal for a total 
of 14 samples. DβH-labeled terminals were unmyelinated and 
varied in size from 0.4–1.5 μm. DβH terminals contained small, 
clear vesicles, though many terminals also contained 1–5 dense-
core vesicles (Figures 3A–F). DβH terminals frequently contained 
mitochondria and some DβH-labeled axons appeared to follow 
the contours of blood vessels (Figure 4A). Frequently, the reaction 
product filled the axoplasm and obscured the morphological fea-
tures of the terminal. Those terminals whose membranes were not 
intact due to the use of detergent were not included in the analysis. 
The vast majority of DβH terminals did not form synapses in a 
single plane of section (282/410 or 69%) (Figures 3A,E). About 
half the DβH terminals (223/410, or 54%) were directly apposed to 
unlabeled terminals (Figures 3B,C,E,F). In some instances (9/410 
or 2%) possible axo–axonic contacts were observed: the plasma 
membranes of DβH terminals showed close and parallel align-
ment with the plasma membrane of unlabeled terminals and some 
intercleft density was present (Figure 4A). When DβH terminals 
did form synapses, most formed symmetric synapses (90/128 or 
70%) (Figure 5A) and the vast majority of these (75/90, 83%) 
occurred on dendrites (Figures 3B,D) though some symmetric 
synapses were made on spines (13/90, 14%) and two occurred on 
somata (2/90, 2%). DβH symmetric synapses on spines usually 
occurred on the spine neck. When DβH terminals formed junc-
tions on spines, almost one-  quarter (9/37 or 24%) of these spines 
received another synapse from an unlabeled terminal. Most of these 
second synapses were asymmetric (8/9 or 89%) and were formed on 
the spine head. Almost one-third of synapse-forming DβH termi-
nals made asymmetric synapses (38/128 or 30%). The majority of 
asymmetric synapses occurred on spines (24/38, or 63%) (Figures 
3F and 5B), though many were formed on dendrites (14/38 or 37%) 
(Figures 3C and 5B).
Figure 2 | Confocal micrographs show that βAr 248 is localized to both 
excitatory and inhibitory LA cells. (A) Cells immunopositive for CAMKII (green) 
are also immunoreactive for βAR 248 (red). Arrows point to dually labeled cells 
while the asterisk indicates a cell singly labeled for βAR 248. (B) GABAergic cells 
(green) also contain βAR 248 (red). Arrows point to cells dually labeled for βAR 
248 and GABA; asterisks indicate βAR 248 singly labeled cells.Frontiers in Behavioral Neuroscience  www.frontiersin.org  October 2010  | Volume 4  | Article 162  |  5
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dIscussIon
The present study used immunocytochemistry to identify and char-
acterize: (1) terminals that contain norepinephrine, and (2) the cel-
lular and subcellular distribution of βARs in the LA. The results 
show that most DβH terminals within the LA do not form synaptic 
junctions, but when they do, most synapses occur on dendritic shafts 
and a small proportion are formed on dendritic spines. While the 
majority of DβH synapses are symmetric, asymmetric synapses are 
also formed and most of these occur on spines. βARs are localized 
to both neurons and glial cells in the LA, and within neurons, βARs 
are localized to both excitatory and inhibitory cells and are frequently 
concentrated at the PSDs of dendritic shafts and spines. These results 
provide the morphological basis for understanding the role that NE 
and βARs play in modulating synaptic transmission within the LA.
Figure 4 | DβH-profiles and glial processes immunoreactive for βAr 404 
are associated with blood vessels. (A) A DβH-axon (LAx) follows the 
contours of a blood vessel. The plasma membrane of the DβH-terminal (DβH) 
shows parallel alignment with the plasma membrane (small arrows) of an 
unlabeled terminal (ut). The basal lamina (asterisks) and an endothelial cell 
(End) separate the DβH-terminal from the blood vessel (BV). (B) A βAR 
404-labeled glial process (LG) encircles a blood vessel (BV), which is bounded 
by an endothelial cell (end) and the basal lamina (asterisks). The βAR 404 
astrocyte apposes unlabeled terminals (ut), one of which forms an asymmetric 
synapse (arrowheads) onto a dendritic spine (sp). Scale bars = 0.500 μm.
Figure 3 | electron micrographs show DβH-terminals in LA. (A) A  
DβH – terminal (DBH) apposes a dendritic spine (sp) and an unlabeled terminal 
(ut) forming an asymmetric synapse (asterisks) onto a spine (sp). (B) A 
DβH-terminal forms a symmetric synapse (arrows) with a dendrite (d). (C) A 
DβH-terminal forms a synapse (arrowheads) onto a dendrite (d) that also 
receives a synapse (arrows) from an unlabeled terminal (ut). Glial processes (g 
and asterisk) are also shown. (D) A DBH-terminal forms a symmetric synapse 
(arrows) onto a dendritic (d) whose spine (sp) receives a synapse (arrowheads) 
from an unlabeled terminal (ut). Also shown is a glial process (g). (e) A 
DβH-terminal is apposed to an unlabeled terminal (ut1) that forms a symmetric 
synapse (arrows) on a dendrite (d). An unlabeled terminal (ut2) forms an 
asymmetric synapse (arrowheads) on the dendrite’s spine (sp). Unlabeled glial 
processes (g and *) are also shown. (F) A DβH-terminal (DBH1) forms a 
synapse (arrows) onto a dendritic shaft (d1), whose spine (sp) receives an 
asymmetric synapse (arrowheads) from a second DβH-terminal (DBH2). DβH2 
apposes unlabeled terminals (ut1–2) forming asymmetric synapses 
(arrowheads) with a spine (sp) and a dendrite (d2). Scale bars = 0.500 μm.
Figure 5 | graphs show synaptic targets and specializations made by DβH terminals that form synapses. (A) The vast majority of DBH symmetric synapses 
occurred on dendrites but a small proportion were made onto spines and somata. (B) Most DBH asymmetric synapses occurred on spines though some were 
formed on dendrites.Frontiers in Behavioral Neuroscience  www.frontiersin.org  October 2010  | Volume 4  | Article 162  |  6
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was used (Aoki et al., 1989; Aoki, 1997). Though the results from 
several autoradiographic (Palacios and Kuhar, 1980; Minneman 
et al., 1982; Rainbow et al., 1984; Johnson et al., 1989) and in situ 
(Asanuma et al., 1991; Abraham et al., 2008) studies report differ-
ent levels of β1- and β2-ARs across various brain regions, each of 
these studies demonstrated the presence of either β1- or β2-ARs 
in the amygdala complex and adjacent areas. Though the pattern 
of βAR immunolabeling we observe is homogenous compared to 
the distinct patterns reported in the autoradiographic and in situ 
studies, the antibodies we used likely recognize receptors in the 
perikaryal cytoplasm undergoing sequestration, desensitization, 
degradation or synthesis, as well as those that are ligand-binding 
(Strader et al., 1987a,b; Zemcik and Strader, 1988). Additionally, 
the antibodies we used recognize both the β1- and the β2-subunits, 
though they were directed against the β2 subunit, and recognize a 
greater population of cells, compared to those identified by in situ. 
It is thus not unexpected that the distribution of βARs identified by 
immunolabeling differs from patterns seen by other methods.
synaptIc characterIzatIon of dβh wIthIn the la
Our results show that most DβH terminals within single planes 
of section do not form synapses but instead form non-junctional 
appositions with dendrites or unlabeled terminals. Though these 
findings are consistent with previous studies showing the non-
junctional nature of DβH terminals in the amygdala (Asan, 1993, 
1998) and other brain regions (Descarries et al., 1977; Seguela 
et al., 1990; Aoki et al., 1998), it is likely that we underestimated 
the degree to which DβH terminals form synapses. Several factors 
might account for our failure to detect these synapses: the use of 
detergent to permeabilize membranes and improve penetration of 
the DβH antibody, dense DAB reaction product that obscures the 
morphological features of labeled terminals, and the thin, small size 
of synapses that may be overlooked without serial section examina-
tion. Though we followed some non-junctional DβH terminals for 
2–5 sections, this series was too small to establish whether these 
DβH terminals ultimately formed synapses. Our results, showing 
that approximately 30% of DβH terminals in the LA form synap-
tic junctions, is higher than what has been reported for the BLA 
(Asan, 1998) and may represent regional differences within the 
amygdala complex or methodological differences attributable to 
our use of a stronger fixative that results in better preservation of 
membrane ultrastructure, enabling detection of a greater number 
of synapses. Our study showing that DβH terminals form both 
symmetric and asymmetric synapses, is consistent with previ-
ous studies done in basal amygdala (Asan, 1998; Li et al., 2002) 
and other brain regions (Seguela et al., 1990; Aoki et al., 1998). 
Though Li et al. (2001) reported that the proportion of symmetric 
and asymmetric synapses was almost equivalent in the BLA, our 
results showing that DβH terminals form approximately twice as 
many symmetric synapses than asymmetric synapses, are similar 
to what Asan (1998) found in BLA. Though asymmetric junc-
tions have been correlated with glutamatergic transmission and 
symmetric synapses with GABAergic transmission (Peters et al., 
1991), the distinction in catecholaminergic systems is less clear and 
may instead reflect the target dendrite and the synaptic machinery 
present on that target. For example, though DβH terminals were 
more likely to form symmetric rather than asymmetric synapses 
MethodologIcal consIderatIons of βar antIsera
The βAR 404 antibody we used in this study was generated by using 
synthetic peptides directed against the amino acid sequences of 
hamster lung β2ARs (Dixon et al., 1986) but recognizes both the 
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immunoprecipitation of radiolabeled βAR (Strader et al., 1987a) and 
preadsorption to the synthetic peptides using the exact correspond-
ence to the antigens that were used to generate the antisera (Aoki, 
1997). Immunolabeling with the antibody directed against the third 
intracellular loop, βAR 248, was consistent with previous studies, in 
which a monoclonal antibody directed the third   intracellular loop 
Figure 6 | Both LA neurons and glia are immunoreactive (ir) for βAr. 
(A) Unlabeled terminals (ut) form asymmetric synapses onto βAR 248-ir 
spines (LSp). The spinous portion (LSp) of a dendrite (d) is βAR 248-ir. (B) An 
unlabeled terminal (ut) synapses (arrowheads) onto a βAR 248-ir spine (LSp). 
βAR 248-labeled terminals (LT1–2) synapse (arrowheads) onto unlabeled spines 
(usp). (C) The βAR 248 reaction product in a dendrite (LD) is concentrated at 
the synapse (arrowheads) formed by an unlabeled terminal (ut) but also rims 
the microtubules (mt) and mitochondria (m). Also shown are a βAR 248-ir 
terminal (LT) and a small labeled dendrite (LD). (D) βAR 404-ir glial processes 
(LG, asterisks) are interposed between two unlabeled terminals (ut1–2). Also 
shown are an unlabeled terminal (ut3) synapsing (arrowheads) onto a βAR 404 
ir spine (LSp) and a βAR 404-ir terminal (LT) synapsing (arrowheads) onto an 
unlabeled spine (usp). (e) A βAR 404-ir glial process (LG) surrounds a terminal 
(ut) that synapses (arrowheads) onto a spine (usp). Asterisks denote βAR 
404-ir along the plasma membrane. (F) A βAR 404 ir glial process (LG, 
asterisks) surrounds an unlabeled terminal (ut) that forms an asymmetric 
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βars at non-synaptIc sItes
The large proportion of non-junctional appositions formed by 
DβH terminals in amygdala may reflect NE release via volume 
transmission (Descarries et al., 1977; Agnati et al., 1995) or non-
synaptic mechanisms. Consistent with these ideas are dual-label 
ultrastructural studies in cortex and hippocampus showing that 
dendrites that are immunoreactive for βAR were near catecho-
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conclusIons
Together, results from this study suggest that norepinephrine-con-
taining terminals in the LA may engage in non-synaptic trans-
mission in the LA. The presence of β2ARs in both excitatory and 
inhibitory neurons suggests that NE has a prolific role in the modu-
lation of synaptic transmission in LA. Further, the prevalence of 
βARs in glial cells adds a further dimension to the role of NE in 
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(Ostroff et al., 2010), we found that when DβH terminals synapse 
on spines, approximately 25% of these spines also receive synapses 
from other unlabeled terminals and most of these junctions are 
asymmetric. This observation and the prevalence of βAR labeling 
at the PSDs of asymmetric synapses in dendritic spines suggest that 
NE may modulate glutamatergic transmission at LA spines. These 
results are consistent with electrophysiological findings showing 
that NE modulates glutamatergic neurotransmission in amygdala 
(Huang et al., 1996, 1998a,b) and activation of βARs enhances 
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LeDoux, 1997, 1999). Thus, NE may modulate synaptic transmis-
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